Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GWAS and drug targets.

BMC genomics - 1 Jan 2014

Cao Chen, Moult John

Abstract excerpt

BACKGROUND: Genome wide association studies (GWAS) have revealed a large number of links between genome variation and complex disease. Among other benefits, it is expected that these insights will lead to new therapeutic strategies, particularly the identification of new drug targets. In this paper, we evaluate the power of GWAS studies to find drug targets by examining how many existing drug targets have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease
Share to Drug Delivery Systems
Share to Gene Regulatory Networks

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Genome-Wide Association Study

Share to Pharmaceutical Preparations

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 25057111
DOI: 10.1186/1471-2164-15-S4-S5
PMCID: PMC4083410

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GWAS and drug targets.PMID 25057111Read ↗

Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunitiesSemantic proximity Read ↗

Network and pathway expansion of genetic disease associations identifies successful drug targets.Semantic proximity Read ↗

Network and pathway expansion of genetic disease associations identifies successful drug targetsSemantic proximity Read ↗

Multi-layered genetic approaches to identify approved drug targetsSemantic proximity Read ↗

Network analysis of genome-wide association studies for drug target prioritisation.Semantic proximity Read ↗

Bringing genome-wide association findings into clinical use.Semantic proximity Read ↗

Open Targets Genetics: An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated lociSemantic proximity Read ↗

Advancing the use of genome-wide association studies for drug repurposing.Semantic proximity Read ↗

Pathway and network-based strategies to translate genetic discoveries into effective therapiesSemantic proximity Read ↗

Benchmarking genome-wide association study causal gene prioritization for drug discoverySemantic proximity Read ↗

The druggable genome and support for target identification and validation in drug developmentSemantic proximity Read ↗

Integration of genetic evidence to identify approved drug targetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.